Rankings
▼
Calendar
NVCR Q2 2024 Earnings — NovoCure Limited Revenue & Financial Results | Market Cap Arena
NVCR
NovoCure Limited
$1B
Q2 2024 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
$150M
+19.3% YoY
Gross Profit
$116M
77.0% margin
Operating Income
-$34M
-22.4% margin
Net Income
-$33M
-22.2% margin
EPS (Diluted)
$-0.31
QoQ Revenue Growth
+8.6%
Cash Flow
Operating Cash Flow
-$2M
Free Cash Flow
-$13M
Stock-Based Comp.
$32M
Balance Sheet
Total Assets
$1.2B
Total Liabilities
$850M
Stockholders' Equity
$362M
Cash & Equivalents
$168M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$150M
$126M
+19.3%
Gross Profit
$116M
$92M
+25.7%
Operating Income
-$34M
-$63M
+46.4%
Net Income
-$33M
-$57M
+41.9%
Geographic Segments
UNITED STATES
$96M
51%
International Markets
$49M
26%
GERMANY
$15M
8%
FRANCE
$14M
8%
JAPAN
$8M
4%
CHINA
$6M
3%
← FY 2024
All Quarters
Q3 2024 →